1416819-91-4 Usage
General Description
The chemical compound "(S)-4-tert-butyl-2-(5-(trifluoroMethyl)pyridin-2-yl)-4,5-dihydrooxazole" is a complex organic molecule with a highly specific composition. It contains a tert-butyl group, a trifluoromethyl group, a pyridinyl group, and an oxazole ring. The (S)-4-tert-butyl-2 configuration refers to the arrangement of atoms in the molecule's structure. (S)-4-tert-butyl-2-(5-(trifluoroMethyl)pyridin-2-yl)-4,5-dihydrooxazole has potential applications in pharmaceuticals, agrochemicals, and other industries due to its unique structural features and properties. It may be used in drug development, material science, and other areas of research and development. Additionally, the trifluoromethyl group in the compound suggests potential for interactions with biological systems and may contribute to its pharmacological or physiological activity. Overall, this chemical compound represents a potentially valuable building block for the synthesis of various biologically active molecules and materials.
Check Digit Verification of cas no
The CAS Registry Mumber 1416819-91-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,1,6,8,1 and 9 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1416819-91:
(9*1)+(8*4)+(7*1)+(6*6)+(5*8)+(4*1)+(3*9)+(2*9)+(1*1)=174
174 % 10 = 4
So 1416819-91-4 is a valid CAS Registry Number.
1416819-91-4Relevant articles and documents
Enantioselective Synthesis of N-Benzylic Heterocycles: A Nickel and Photoredox Dual Catalysis Approach
Pezzetta, Cristofer,Bonifazi, Davide,Davidson, Robert W. M.
supporting information, p. 8957 - 8961 (2019/11/11)
Reported herein is a dual nickel- and photoredox-catalyzed modular approach for the preparation of enantioenriched N-benzylic heterocycles. α-Heterocyclic carboxylic acids, easily obtainable from common commercial material, are reported as suitable substrates for a decarboxylative strategy in conjunction with a chiral pyridine-oxazoline (PyOx) ligand, providing quick access to enantioenriched drug-like products. The presence of a directing group on the heterocyclic moiety is shown to be beneficial, affording improved stereoselectivity in a number of cases.
